Clinical Trial Update: A Study of ZL-1211 in Patients With Advanced Solid Tumor [Phase 1]

View source ↗

Summary

A Phase 1 study of ZL-1211 in patients with advanced solid tumors has completed, with the update noting the trial status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• ZL-1211

Snippet

Sponsor: Zai Biopharmaceutical (Suzhou) Co., Ltd. | Conditions: Advanced Solid Tumor | Phase 1 | Status: COMPLETED